News
Endovastec™ Minos™ Receives Approval for Marketing in Colombia - 02 Sep 2022
Endovastec™ recently received registration approval from the Colombian...MicroPort® Announces 2022 Interim Results - 01 Sep 2022
MicroPort® announced the interim results of the Group and its subsidia...MicroPort EP Listed on the SSE STAR Market - 31 Aug 2022
First innovative medical device company goes public on the STAR Market...CardioFlow Medtech Announces 2022 Interim Results - 30 Aug 2022
CardioFlow Medtech announced the interim results of the Company and it...MicroPort NeuroTech™ Announces 2022 Interim Results - 27 Aug 2022
MicroPort NeuroTech™ today announced the interim results of the Compan...MicroPort NeuroTech™ NUMEN Receives Marketing Approval in Japan - 27 Aug 2022
MicroPort NeuroTech™ has received marketing approval issued by Ministr...MicroPort® MedBot™ Announces 2022 Interim Results - 26 Aug 2022
MicroPort® MedBot™ today announced the interim results of the Company ...Endovastec™ Announces 2022 Interim Results - 25 Aug 2022
Endovastec™ today announced the interim results of the Company and its...MicroPort NeuroTech™ APOLLO™ Completes First Implantation in Brazil - 19 Aug 2022
MicroPort NeuroTech™ recently announced that its independently develop...VitaFlow Liberty™ Obtains Marketing Approval in Colombia - 19 Aug 2022
CardioFlow Medtech recently announced VitaFlow Liberty™ has received m...MicroPort NeuroTech™ Completes First Implantation of NUMEN™ in Poland - 11 Aug 2022
MicroPort NeuroTech™ recently announced that its independently develop...MicroPort® MedBot™ JV’s R-ONE™ Completes Registration Clinical Trial - 01 Aug 2022
Shanghai Cathbot™ recently announced the completion of the clinical tr...MSC Announces First Clinical Use of TheFirst Rega™ Pacemaker in China - 28 Jul 2022
MSC recently announced the first batch of the Rega™ MRI-conditional im...Firehawk Pro™ Receives NMPA Approval for Marketing - 20 Jul 2022
MicroPort® has received approval from the Chinese NMPA to market its F...MicroPort NeuroTech™ Debuts on Main Board of HKEX - 15 Jul 2022
As the Pioneer & Largest Chinese Player in the Neuro-interventional Me...MicroPort® CRM Gets CE Mark Approval for INVICTA™ Defibrillation Leads - 13 Jul 2022
MicroPort® CRM has recently received CE Mark approval for its INVICTA™...